Shoulder Innovations Reports Strong Q1 Revenue Growth, Raises Full-Year Guidance
SI sits 32% above its 52-week low of $10.92.
Summary
Shoulder Innovations reported strong first-quarter 2026 financial results, with net revenue increasing 65% year-over-year, and raised its full-year 2026 revenue guidance.
Key Events · Earnings and Guidance · SI
-
Strong Q1 Revenue Growth
Net revenue for the first quarter of 2026 increased 65% year-over-year to $16.7 million, driven by a 51% increase in implant systems sold.
-
Raised Full-Year Guidance
The company increased its full-year 2026 net revenue guidance to a range of $65 million to $68 million, up from the prior guidance of $62 million to $65 million.
-
Improved Gross Margin
Gross margin for the first quarter improved to 77.7% compared to 76.9% in the same period last year.
-
Increased Operating Losses
Operating loss widened to $9.0 million from $4.3 million in Q1 2025, primarily due to increased investments in commercial organization and research and development.
Analysis · SI · Industrial Applications And Services
Shoulder Innovations delivered robust first-quarter results, significantly exceeding prior year performance with 65% revenue growth and a 51% increase in implant system sales. The company's decision to raise its full-year revenue guidance signals strong operational momentum and increased confidence in its growth trajectory, despite continued investments in commercial expansion and R&D leading to higher losses.
At the time of this filing, SI was trading at $14.42 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $279.4M. The 52-week trading range was $10.92 to $17.94. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.